We used three EphA2-positive PDX models of bladder cancer (Figure S2), and we compared EphA2-ILs-DTXp to equitoxic dosing of free docetaxel (Figure 3 and statistical summary—Table 2), as previously determined in naïve mice [30]. This evidence concerns the gene EPHA2 and urinary bladder cancer.